Lack of knowledge, decision-making difficulties among factors identified with non-follow-up
FRIDAY, Dec. 2, 2022 (HealthDay News) — Lack of knowledge and decision-making difficulties are associated with non-follow-up to positive fecal immunochemical test (FIT) results, according to a study published in the November/December issue of the Annals of Family Medicine.
Lucinda S. Bertels, Ph.D., from the University of Amsterdam, and colleagues surveyed 2,225 participants in the Dutch CRC screening program who received a positive FIT to understand factors associated with non-follow-up.
The researchers found that one-third of respondents reported no colonoscopy, with more than half (55 percent) reporting a contraindication. Non-follow-up was associated with decisional difficulties (odds ratio [OR], 0.29), lacking the opportunity to discuss the FIT outcome (OR, 0.45), and a low estimated risk for colorectal cancer (CRC; OR, 0.45). Having an alternative explanation for the positive FIT (OR, 0.3), having trust in the ability to self-detect CRC (OR, 0.42), and thinking that polyp removal is ineffective (OR, 0.59) were also negatively associated with follow-up. The strongest factor associated with follow-up was the belief that the family physician would support colonoscopy (OR, 2.84).
“Improving knowledge levels and offering personal guidance, possibly in the form of personalized screening counseling, as well as the involvement of family physicians, might prove beneficial for some FIT-positive individuals,” the authors write.
Urine Cell-Free RNA Shows Promise as Biomarker for Bladder Cancer
Age-, Joint-Specific Ultrasound Reference Values Set for Healthy Joints
Surveillance Colonoscopy at Five Years After Adenoma Removal Noninferior to Three Years
Family History of CRC Increases CRC Risk Similarly in IBD, General Population
Personalized Support Boosts Families" Genetic Testing for Hereditary Cancers
Serum 25(OH)D May Serve as Biomarker of Disease Activity in IBD
Gene Mutation Identified That Increases Lung Cancer Risk
Genetics, Diabetes Tied to MASLD-Associated Cirrhosis Before Age 50